Clinical Trials in Ohio

Showing 19461-19480 of 20,938 trials

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

NCT00291551

This is a limited safety and feasibility study to evaluate the PVSS Introducer and Paracor Ventricular Support System when used to treat patients with heart failure. The implant, which is loaded onto the delivery system, is placed over the epicardial surface of the right and left ventricles. No formal hypothesis testing will be performed; descriptive statistics will be used to summarize patient outcomes. The results of the study will be used to guide the design and sample size estimation of future studies.

Heart Failure, Congestive

Paracor Medical, Inc39 participantsStarted Jan 2005

Birmingham, Alabama, United States • Denver, Colorado, United States • Gainesville, Florida, United States +9 more locations

TERMINATEDPhase 232 miles

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer

NCT00607438

This is a Phase II, open-label, non-randomized study in patients with locally advanced or metastatic breast cancer. Each cycle will be 4 weeks in length. Patients will receive Abraxane weekly for 3 weeks. Patients will not receive Abraxane during week 4 (rest week). Nexavar will be given continuously. Patients will be radiologically evaluated every 8 weeks for response. Patients will continue to receive study treatment until disease progression or unacceptable toxicity.

Breast Cancer

Veeda Oncology16 participantsStarted Sep 2007

Columbus, Ohio, United States

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer

Find Trials by Condition in Ohio

A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Safety Study of AMI MultiStem® to Treat Heart Attacks

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty

Breast Cancer Screening Via Computer V. Phone

Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients

Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Dose Finding Posterolateral Thoracotomy Study